A Plus Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	825.52	769.59	675.05	541.85	503.29
Revenue Growth (YoY)	11.83%	14.01%	24.58%	7.66%	-
Cost of Revenue	251.55	234.81	214.37	195.46	185.36
Gross Profit	573.97	534.78	460.67	346.39	317.93
Selling, General & Admin	319.04	299.15	233.43	237.16	203.12
Research & Development	45.26	53.34	59.54	63.08	79.96
Operating Expenses	364.3	352.32	293.13	299.65	275.4
Operating Income	209.67	182.46	167.54	46.74	42.53
Interest Expense	-2.17	-2.19	-2.69	-2.2	-1.19
Interest & Investment Income	2.81	2.27	1.71	0.42	2.05
Currency Exchange Gain (Loss)	-0.01	1.68	0.03	-	-
Other Non Operating Income (Expenses)	0.57	3.35	-163.59	1.1	4.36
EBT Excluding Unusual Items	212.86	187.57	3	46.06	47.75
Gain (Loss) on Sale of Assets	-0	-0.01	-	-	-
Other Unusual Items	0.02	-	0.04	-	-
Pretax Income	212.87	187.56	3.04	46.06	47.75
Income Tax Expense	41.21	36.5	14.34	10.43	8.71
Earnings From Continuing Operations	171.66	151.06	-11.31	35.63	39.04
Minority Interest in Earnings	-0.12	-	-	-2.69	-2.97
Net Income	171.54	151.06	-11.31	32.94	36.06
Net Income to Common	171.54	151.06	-11.31	32.94	36.06
Net Income Growth	1135.00%	-	-	-8.66%	-
Shares Outstanding (Basic)	32	30	30	29	29
Shares Outstanding (Diluted)	32	30	30	29	29
Shares Change (YoY)	5.53%	0.37%	4.70%	0.95%	-
EPS (Basic)	5.40	4.99	-0.37	1.15	1.26
EPS (Diluted)	5.38	4.97	-0.37	1.14	1.26
EPS Growth	1069.88%	-	-	-9.52%	-
Free Cash Flow	145.39	152.09	149.72	-168.55	107.35
Free Cash Flow Per Share	4.56	5.01	4.95	-5.83	3.75
Dividend Per Share	4.000	4.000	0.900	-	-
Dividend Growth	344.44%	344.44%	-	-	-
Gross Margin	69.53%	69.49%	68.24%	63.93%	63.17%
Operating Margin	25.40%	23.71%	24.82%	8.63%	8.45%
Profit Margin	20.78%	19.63%	-1.68%	6.08%	7.17%
Free Cash Flow Margin	17.61%	19.76%	22.18%	-31.11%	21.33%
EBITDA	225.07	197.32	181.35	68.17	68.01
EBITDA Margin	27.27%	25.64%	26.86%	12.58%	13.51%
D&A For EBITDA	15.4	14.86	13.81	21.43	25.48
EBIT	209.67	182.46	167.54	46.74	42.53
EBIT Margin	25.40%	23.71%	24.82%	8.63%	8.45%
Effective Tax Rate	19.36%	19.46%	472.12%	22.64%	18.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.